Autopsy report · NCT03391791
Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors
Cause of deathSlow enrollment
“terminated after participants were enrolled”
Life of this trial
- Registered 2 months before it started.
- Ran for about 5 months before it stopped.
- 2 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Adaptimmune
- Sponsor type
- Industry
- Conditions
- Solid and Hematological Malignancies
- Interventions
- Genetically engineered T Cell Receptors
- Participants
- 2
- Sites
- 3
- Countries
- Canada, United States
Trials that died the same way
- Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment
“Enrollment terminated due to not having any other eligible participants.” - Teens Coping With Parental Military Deployment
“Terminated due to difficuly recruiting participants” - Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy
“Terminated due to lack of enrollment” - Polycystic Liver Disease in Kidney Transplant
“Terminated due to inadequate enrollment” - An Investigator-initiated Study to Evaluate Safety and Efficacy of ARINA-1 in People With a Tracheostomy
“Terminated due to enrollment challenges”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.